we are investigating the efficacy of patient controlled paravertebral anaesthesia in the post-operative pain control of patients undergoing breast surgery. Therefore the medical condition is post operative pain control in breast surgical patients
Conditions
Interventions
Trade Name: chirocaine
Product Name: laevobupivicaine
Pharmaceutical Form: Solution for injection
Sponsors
None listed
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients for breast surgery who are not day cases. Patients who have had the advantages and disadvantages of paravertebral anaesthesia explained to them and have consented to the study. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Patient refusal. Patients for whom PVA is contraindicated (e.g. local infection, severe coagulopathy) Patients with allergy to any of the drugs to be included.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: the objective of our study is to evaluate the efficacy of Patient Controlled Paravertebral Anaesthesia (PCPA) for postoperative analgesia after breast surgery. ;Secondary Objective: ;Primary end point(s): 1.Pain scores at rest and on movement, measured on a 100mm visual analogue scale (VAS), recorded every four hours. 2.Rescue analgesic requirements | — |
Countries
Ireland
Outcome results
None listed